(1S,6R,8R,9R)-8-(6-aminopurin-9-yl)-3-hydroxy-3-oxo-2,4,7-trioxa-3$l^{5}-phosphabicyclo[4.3.0]nonan-9-ol;(1S,6R,8R,9R)-8-(6-amino-9-purinyl)-3-hydroxy-3-oxo-2,4,7-trioxa-3$l^{5}-phosphabicyclo[4.3.0]nonan-9-ol;(1S,6R,8R,9R)-8-(6-aminopurin-9-yl)-3-hydroxy-3-keto-2,4,7-trioxa-3$l^{5}-phosphabicyclo[4.3.0]nonan-9-ol;11002-78-1;54532-48-8;(4aR,6R,7R,7aS)-6-(6-Aminopurin-9-yl)-2-oxo-tetrahydro-2-lambda*5*-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol;4H-Furo[3,2-d]-1,3,2-dioxaphosphorin, adenosine deriv.;4H-furo[3,2-d]-1,3,2-dioxaphosphorin-7-ol, 6-(6-amino-9H-purin-9-yl)tetrahydro-2-hydroxy-, 2-oxide, (4aR,6R,7R,7aS)-;Adenosine 3',5'-cyclic phosphate;EU-0100084;3&#8242;,5&#8242;-Cyclic AMP;A9501_SIGMA;Adenosine 3&#8242;,5&#8242;-cyclic monophosphate;Adenosine 3&#8242;,5&#8242;-cyclophosphate;Lopac0_000084;ST5298854;(S)-1-C-(7-Amino-1H-pyrazolo(4,3-d)pyrimidine-3-yl)-1,4-anhydro-D-ribitol cyclic 3',5'-(hydrogen phosphate);D-Ribitol, 1-C-(7-amino-1H-pyrazolo(4,3-d)pyrimidine-3-yl)-1,4-anhydro-, cyclic 3',5'-(hydrogen phosphate), (S)-;Formycin cyclic 3',5'-monophosphate;Adenosine cyclic 3',5'-(hydrogen phosphate);Adenosine 3',5'-cyclophosphoric acid;cyclic Adenosine 3',5'-phosphate;ADENOSINE-3',5'-CYCLIC-MONOPHOSPHATE;3',5'-AMP;4-26-00-03618 (Beilstein Handbook Reference);Adenosine 3',5'-cyclic monophosphate;Adenosine 3',5'-cyclophosphate;Adenosine 3',5'-monophosphate;Adenosine 3',5'-phosphate monohydrate;Adenosine cyclic 3',5'-monophosphate;Adenosine cyclic 3',5'-phosphate;Adenosine cyclic monophosphate;Adenosine, cyclic 3',5'-(hydrogen phosphate);BRN 0052645;CCRIS 4291;CYCLIC-3',5'-(HYDROGEN PHOSPHATE)ADENOSINE;EINECS 200-492-9;NSC 94017;cyclic 3',5'-Adenylic acid;cyclic Adenosine 3',5'-monophosphate;Adenosine 3',5'-phosphate;C00575;Cyclic AMP;Cyclic adenylic acid;AIDS-008698;CMP;AIDS008698;Adenosine-3',5'-cyclicmonophosphate;CHEBI:17489;adenosine 3',5'-(hydrogen phosphate)
(1S,6R,8R,9R)-8-(6-aminopurin-9-yl)-3-hydroxy-3-oxo-2,4,7-trioxa-3$l^{5}-phosphabicyclo[4.3.0]nonan-9-ol